Compare ZNTL & YOUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZNTL | YOUL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 107.2M |
| IPO Year | 2020 | N/A |
| Metric | ZNTL | YOUL |
|---|---|---|
| Price | $1.34 | $1.49 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 788.9K | N/A |
| Earning Date | 11-10-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,865,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | N/A |
| 52 Week High | $3.33 | N/A |
| Indicator | ZNTL | YOUL |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | N/A |
| Support Level | $1.32 | N/A |
| Resistance Level | $1.46 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 23.53 | 0.00 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Youlife Group Inc is a blue-collar lifetime service provider with a nationwide network of 25 vocational schools under school management model and 25 curriculum development projects, covering a total of 37 cities or counties under 16 provinces of China.